Nintedanib in Patients With Advanced Esophagogastric Cancer
Clinical trial NCT02234596 · COMPLETED
Trial details
- NCT number
- NCT02234596
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-04
- Primary completion
- 2020-04-22
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.